Seagen Inc. [SGEN]

Source: 

Company Overview

Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. We are commercializing ADCETRIS  , or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV  , or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TUKYSA  , or tucatinib, for the treatment of certain metastatic HER2-positive breast and colorectal cancers, and TIVDAK  , or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers.